Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 177

1.

Interferon gamma regulates accumulation of the proteasome activator PA28 and immunoproteasomes at nuclear PML bodies.

Fabunmi RP, Wigley WC, Thomas PJ, DeMartino GN.

J Cell Sci. 2001 Jan;114(Pt 1):29-36.

3.

Caspases mediate retinoic acid-induced degradation of the acute promyelocytic leukemia PML/RARalpha fusion protein.

Nervi C, Ferrara FF, Fanelli M, Rippo MR, Tomassini B, Ferrucci PF, Ruthardt M, Gelmetti V, Gambacorti-Passerini C, Diverio D, Grignani F, Pelicci PG, Testi R.

Blood. 1998 Oct 1;92(7):2244-51.

5.
6.
8.

The disruption of ND10 during herpes simplex virus infection correlates with the Vmw110- and proteasome-dependent loss of several PML isoforms.

Everett RD, Freemont P, Saitoh H, Dasso M, Orr A, Kathoria M, Parkinson J.

J Virol. 1998 Aug;72(8):6581-91.

10.

Primary structures of two homologous subunits of PA28, a gamma-interferon-inducible protein activator of the 20S proteasome.

Ahn JY, Tanahashi N, Akiyama K, Hisamatsu H, Noda C, Tanaka K, Chung CH, Shibmara N, Willy PJ, Mott JD, et al.

FEBS Lett. 1995 Jun 5;366(1):37-42.

11.

Regulation of proteasome complexes by gamma-interferon and phosphorylation.

Rivett AJ, Bose S, Brooks P, Broadfoot KI.

Biochimie. 2001 Mar-Apr;83(3-4):363-6. Review.

PMID:
11295498
12.

Disruption of PML-associated nuclear bodies mediated by the human cytomegalovirus major immediate early gene product.

Wilkinson GW, Kelly C, Sinclair JH, Rickards C.

J Gen Virol. 1998 May;79 ( Pt 5):1233-45.

PMID:
9603339
13.

The coiled-coil domain is the structural determinant for mammalian homologues of Drosophila Sina-mediated degradation of promyelocytic leukemia protein and other tripartite motif proteins by the proteasome.

Fanelli M, Fantozzi A, De Luca P, Caprodossi S, Matsuzawa S, Lazar MA, Pelicci PG, Minucci S.

J Biol Chem. 2004 Feb 13;279(7):5374-9. Epub 2003 Nov 25.

14.
15.

Differential influence on cytotoxic T lymphocyte epitope presentation by controlled expression of either proteasome immunosubunits or PA28.

van Hall T, Sijts A, Camps M, Offringa R, Melief C, Kloetzel PM, Ossendorp F.

J Exp Med. 2000 Aug 21;192(4):483-94.

17.
18.

Role and fate of PML nuclear bodies in response to interferon and viral infections.

Regad T, Chelbi-Alix MK.

Oncogene. 2001 Oct 29;20(49):7274-86. Review.

19.
20.

Simultaneous binding of PA28 and PA700 activators to 20 S proteasomes.

Hendil KB, Khan S, Tanaka K.

Biochem J. 1998 Jun 15;332 ( Pt 3):749-54.

Supplemental Content

Support Center